eli lilly zepbound sleep apnea news - Search News

Eli Lilly Gets FDA Approval for Zepbound

Hosted on MSN · 2d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

ConsumerAffairs · 7h

FDA approves Zepbound as a treatment for obstructive sleep apnea

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and Drug Administration has appro

38mon MSN

Does This News From the FDA Make Eli Lilly a Buy for 2025?

Eli Lilly (NYSE: LLY) soared more than 60% from the start of the year through its peak this summer, thanks to the company's ...

13m

Stocks to Watch Monday: Honda, Nissan, Novo Nordisk, Eli Lilly

The Japanese c ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results